SCHEMBL18907253

SCHEMBL18907253

c1ccc(-c2nc3c4ccccc4ccc3c3c2cc(-c2c4ccccc4c(-c4ccc5c(c4)nc(-c4ccccc4)c4ccc6c7ccccc7oc6c45)c4ccccc24)c2ccccc23)cc1

nearest known ligand 0.32

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.32
MAPK1 P28482 1/20 0.32
MAPT P10636 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MEN1 O00255 1/20 0.31
CSF1R P07333 1/20 0.31
PDGFRB P09619 1/20 0.31
KIT P10721 1/20 0.31
FLT3 P36888 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18907208 0.93 ALOX5 (0.34) KMT2AMAPK1MAPTKDM4EALDH1A1
SCHEMBL18907247 0.92 TDP1 (0.34) KMT2AMAPTMEN1CSF1RPDGFRB
SCHEMBL18842530 0.92 MAPT (0.34) KMT2AMAPTKDM4EALDH1A1HPGD
SCHEMBL18907246 0.91 KMT2A (0.32) KMT2AMAPK1MAPTKDM4EALDH1A1
SCHEMBL18907241 0.90 ALOX5 (0.34) KMT2AMAPK1MAPTKDM4EALDH1A1
SCHEMBL18907264 0.90 ESR1 (0.37) KMT2AMAPTHSD17B10MEN1CSF1R
SCHEMBL18842509 0.88 L3MBTL1 (0.36) KMT2AMAPK1MAPTKDM4EALDH1A1
SCHEMBL18842510 0.86 L3MBTL1 (0.35) KMT2AMAPK1MAPTKDM4EALDH1A1
SCHEMBL18907187 0.86 ALOX5 (0.38) KMT2AMAPK1MAPTKDM4EALDH1A1
SCHEMBL18842513 0.86 ALOX5 (0.38) KMT2AMAPK1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 KMT2A 2503/4885MAPK1 366/4885MAPT 2043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.